References
- P. T. Kamatham, R. Shukla, D. K. Khatri and L. K. Vora, Pathogenesis, diagnostics, and therapeutics for Alzheimer’s disease: Breaking the memory barrier, Ageing Res. Rev. 101 (2024) Article ID 102481 (23 pages); https://doi.org/10.1016/j.arr.2024.102481
- X. Xia, Q. Jiang, J. McDermott and J. J. Han, Aging and Alzheimer’s disease: Comparison and associations from molecular to system level, Aging Cell 17(5) (2018) e12802 (14 pages); https://doi.org/10.1111/acel.12802
- Alzheimer’s Association, 2024 Alzheimer’s disease facts and figures, Alzheimers Dement. 20(5) (2024) 3708–3821; https://doi.org/10.1002/alz.13809
- A. A. Rostagno, Pathogenesis of Alzheimer’s disease, Int. J. Mol. Sci. 24(1) (2023) Article ID 107 (4 pages); https://doi.org/10.3390/ijms24010107
- S. Tiwari, V. Atluri, A. Kaushik, A. Yndart and M. Nair, Alzheimer’s disease: Pathogenesis, diagnostics, and therapeutics, Int. J. Nanomed. 14 (2019) 5541–5554; https://doi.org/10.2147/IJN.S200490
- N. Guo, X. Wang, M. Xu, J. Bai, H. Yu and Z. Le, PI3K/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression, Pharmacol. Res. 206 (2024) Article ID 107300 (12 pages); https://doi.org/10.1016/j.phrs.2024.107300
- J. Pan, Q. Yao, Y. Wang, S. Chang, C. Li, Y. Wu, J. Shen and R. Yang, The role of PI3K signaling pathway in Alzheimer’s disease, Front. Aging Neurosci. 16 (2024) Article ID 1459025 (17 pages); https://doi.org/10.3389/fnagi.2024.1459025
- S. Davoody, A. Asgari Taei, P. Khodabakhsh and L. Dargahi, mTOR signaling and Alzheimer’s disease: What we know and where we are?, CNS Neurosci. Ther. 30(4) (2024) e14463 (17 pages); https://doi.org/10.1111/cns.14463
- W. Li, P. He, Y. Huang, Y. F. Li, J. Lu, M. Li, H. Kurihara, Z. Luo, T. Meng, M. Onishi, C. Ma, L. Jiang, Y. Hu, Q. Gong, D. Zhu, Y. Xu, R. Liu, L. Liu, C. Yi, Y. Zhu, N. Ma, K. Okamoto, Z. Xie, J. Liu, R. R. He and D. Feng, Selective autophagy of intracellular organelles: Recent research advances, Theranostics 11(1) (2021) 222–256; https://doi.org/10.7150/thno.49860
- Y. Zhao, Y. Zhang, J. Zhang, X. Zhang and G. Yang, Molecular mechanism of autophagy: Its role in the therapy of Alzheimer’s disease, Curr. Neuropharmacol. 18(8) (2020) 720–739; https://doi.org/10.2174/1570159X18666200114163636
- M. Eshraghi, A. Adlimoghaddam, A. Mahmoodzadeh, F. Sharifzad, H. Yasavoli-Sharahi, S. Lorzadeh, B. C. Albensi and S. Ghavami, Alzheimer’s disease pathogenesis: Role of autophagy and mitophagy focusing on microglia, Int. J. Mol. Sci. 22(7) (2021) Article ID 3330 (36 pages); https://doi.org/10.3390/ijms22073330
- Z. Zhang, X. Yang, Y. Q. Song and J. Tu, Autophagy in Alzheimer’s disease pathogenesis: Therapeutic potential and future perspectives, Ageing Res. Rev. 72 (2021) Article ID 101464 (15 pages); https://doi.org/10.1016/j.arr.2021.101464
- N. Mizushima, Autophagic flux measurement: Cargo degradation versus generation of degradation products, Curr. Opin. Cell Biol. 93 (2025) Article ID 102463 (8 pages); https://doi.org/10.1016/j.ceb.2025.102463
- L. Gomez-Virgilio, M. D. Silva-Lucero, D. S. Flores-Morelos, J. Gallardo-Nieto, G. Lopez-Toledo, A. M. Abarca-Fernandez, A. E. Zacapala-Gomez, J. Luna-Munoz, F. Montiel-Sosa, L. O. Soto-Rojas, M. Pacheco-Herrero and M. D. Cardenas-Aguayo, Autophagy: A key regulator of homeostasis and disease – An overview of molecular mechanisms and modulators, Cells 11(15) (2022) Article ID 2262 (40 pages); https://doi.org/10.3390/cells11152262
- Z. Deng, Y. Dong, X. Zhou, J. H. Lu and Z. Yue, Pharmacological modulation of autophagy for Alzheimer’s disease therapy: Opportunities and obstacles, Acta Pharm. Sin. B 12(4) (2022) 1688–1706; https://doi.org/10.1016/j.apsb.2021.12.009
- H. Leysen, D. Walter, L. Clauwaert, L. Hellemans, J. van Gastel, L. Vasudevan, B. Martin and S. Maudsley, The relaxin-3 receptor RXFP3 is a modulator of aging-related disease, Int. J. Mol. Sci. 23(8) (2022) Article ID 4387 (22 pages); https://doi.org/10.3390/ijms23084387
- S. Ma, C. M. Smith, A. Blasiak and A. L. Gundlach, Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain, Br. J. Pharmacol. 174(10) (2017) 1034–1048; https://doi.org/10.1111/bph.13659
- D. J. Scott, K. J. Rosengren and R. A. Bathgate, The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2, Mol. Endocrinol. 26(11) (2012) 1896–1906; https://doi.org/10.1210/me.2012-1188
- J. R. Kumar, R. Rajkumar, T. Jayakody, S. Marwari, J. M. Hong, S. Ma, A. L. Gundlach, M. K. P. Lai and G. S. Dawe, Relaxin’ the brain: Targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders, Br. J. Pharmacol. 174(10) (2016) 1061–1076; https://doi.org/10.1111/bph.13564
- M. E. S. Sorial, R. M. Abdelghany and N. El Sayed, Modulation of the cognitive impairment associated with Alzheimer’s disease by valproic acid: Possible drug repurposing, Inflammopharmacology 33(4) (2025) 2083–2094; https://doi.org/10.1007/s10787-025-01695-0
- M. Levin-Arama, L. Abraham, T. Waner, A. Harmelin, D. M. Steinberg, T. Lahav and M. Harlev, Subcutaneous compared with intraperitoneal ketamine-xylazine for anesthesia of mice, J. Am. Assoc. Lab. Anim. Sci. 55(6) (2016) 794–800.
- D. Kaur, A. K. Grewal, S. H. Almasoudi, A. H. Almehmadi, B. A. Alsfouk, A. Kumar, V. Singh, A. Alexiou, M. Papadakis, N. N. Welson, T. G. Singh and G. E.-S. Batiha, Neuroprotective effect of tozasertib in streptozotocin-induced Alzheimer’s mice model, Sci. Rep. 15 (2025) Article ID 28963 (16 pages); https://doi.org/10.1038/s41598-025-13920-5
- G. M. Shankar, M. A. Leissring, A. Adame, X. Sun, E. Spooner, E. Masliah, D. J. Selkoe, C. A. Le-mere and D. M. Walsh, Biochemical and immunohistochemical analysis of an Alzheimer’s disease mouse model reveals multiple cerebral amyloid-β assembly forms, Neurobiol. Dis. 36(2) (2009) 293–302; https://10.1016/j.nbd.2009.07.021
- L. J. Lissner, K. M. Wartchow, A. P. Toniazzo, C. A. Goncalves and L. Rodrigues, Object recognition and Morris water maze to detect cognitive impairment from mild hippocampal damage in rats, Pharmacol. Biochem. Behav. 210 (2021) Article ID 173273 (9 pages); https://doi.org/10.1016/j.pbb.2021.173273
- A. Vogel-Ciernia and M. A. Wood, Examining object location and object recognition memory in mice, Curr. Protoc. Neurosci. 69 (2014) 8.31.1-8.31.17; https://doi.org/10.1002/0471142301.ns0831s69
- R. Rajmohan and P. H. Reddy, Amyloid-β and phosphorylated tau accumulations cause synaptic abnormalities in Alzheimer’s disease neurons, J. Alzheimer’s Dis. 57(4) (2017) 975–999; https://doi.org/10.3233/JAD-160612
- H. Dong, C. M. Yuede, C. A. Coughlan, K. M. Murphy and J. G. Csernansky, Effects of donepezil on amyloid-β and synapse density in the Tg2576 mouse model of Alzheimer’s disease, Brain Res. 1303 (2009) 169–178; https://doi.org/10.1016/j.brainres.2009.09.097
- K. Dasuri, L. Zhang, S. O. Kim, A. J. Bruce-Keller and J. N. Keller, Dietary and donepezil modulation of mammalian target of rapamycin signaling and neuroinflammation in the brain, Biochim. Biophys. Acta Mol. Basis Dis. 1862(2) (2016) 274–283; https://doi.org/10.1016/j.bbadis.2015.11.002
- S. Bathina and U. N. Das, Dysregulation of the PI3K-Akt-mTOR pathway in the brain of streptozotocin-induced type 2 diabetic rats, Lipids Health Dis. 17 (2018) Article ID 168 (11 pages); https://doi.org/10.1186/s12944-018-0809-2
- Y. Fu, J. Zhang, R. Qin, Y. Ren, T. Zhou, B. Han and B. Liu, Activating autophagy to eliminate toxic protein aggregates in neurodegenerative diseases, Pharmacol. Rev. 77(3) (2025) Article ID 100053 (50 pages); https://doi.org/10.1016/j.pharmr.2025.100053
- Q. Wang, Y. Wang, S. Li and J. Shi, PACAP-sirtuin-3 alleviates cognitive impairment through autophagy in Alzheimer’s disease, Alzheimers Res. Ther. 15(1) (2023) Article ID 184 (20 pages); https://doi.org/10.1186/s13195-023-01334-2
- S. Guo, L. Yi, M. Luo, Z. Dong and Y. Du, Parishin A ameliorates cognitive decline by promoting PS1 autophagy in Alzheimer’s disease, Front. Aging Neurosci. 17 (2025) Article ID 1516190 (16 pages); https://doi.org/10.3389/fnagi.2025.1516190
- F. Islam, M. H. Nafady, M. R. Islam, S. Saha, S. Rashid, S. Akter, M. H. Or-Rashid, M. F. Akhtar, A. Perveen, G. M. Ashraf, H. M. Rahman and S. H. Sweilam, Resveratrol and neuroprotection against Alzheimer’s disease, Mol. Neurobiol. 59(7) (2022) 4384–4404; https://doi.org/10.1007/s12035-022-02859-7
- Y. Chen and Y. Yu, Tau and neuroinflammation in Alzheimer’s disease: Interplay mechanisms and clinical translation, J. Neuroinflammation 20(1) (2023) Article ID 165 (21 pages); https://doi.org/10.1186/s12974-023-02853-3
- P. J. Ryan, E. Buchler, F. Shabanpoor, M. A. Hossain, J. D. Wade, A. J. Lawrence and A. L. Gundlach, Central RXFP3 activation decreases anxiety- and depressive-like behaviours in rats, Behav. Brain Res. 244 (2013) 142–151; https://doi.org/10.1016/j.bbr.2013.01.034
- S. W. Jere, N. N. Houreld and H. Abrahamse, Role of PI3K/AKT (mTOR and GSK-3β) signaling in diabetic wound healing, Cytokine Growth Factor Rev. 50 (2019) 52–59; https://doi.org/10.1016/j.cytogfr.2019.03.001
- C. Z. Yang, S. H. Wang, R. H. Zhang, J. H. Lin, Y. H. Tian, Y. Q. Yang, J. Liu and Y. X. Ma, Neuro-protective effect of astragalin via activating PI3K/Akt-mTOR-mediated autophagy on APP/PS1 mice, Cell Death Discov. 9 (2023) Article ID 15 (13 pages); https://doi.org/10.1038/s41420-023-01324-1
- S. A. El-Maraghy, A. Reda, R. M. Essam and M. A. Kortam, The citrus flavonoid “Nobiletin” impedes STZ-induced Alzheimer’s disease in a mouse model through regulating autophagy mastered by SIRT1/FoxO3a mechanism, Inflammopharmacology 31(5) (2023) 2701–2717; https://doi.org/10.1007/s10787-023-01292-z
- Q. Qiu, X. Lei, Y. Wang, H. Xiong, Y. Xu, H. Sun, H. Xu and N. Zhang, Naringin protects against tau hyperphosphorylation via ER, PI3K/Akt and GSK-3β signaling, Behav. Neurol. 2023 (2023) Article ID 1857330 (16 pages); https://doi.org/10.1155/2023/1857330
- M. A. Salem, B. Budzynska, J. Kowalczyk, N. S. El Sayed and S. M. Mansour, Tadalafil and bergapten mitigate STZ-induced sporadic Alzheimer’s disease via PI3K/Akt, Wnt/β-catenin and AMPK/mTOR pathways, Toxicol. Appl. Pharmacol. 429 (2021) Article ID 115697 (14 pages); https://doi.org/10.1016/j.taap.2021.115697